Merz Pharmaceutical is an innovative pharmaceutical company that carries out research, develops, manufactures and sells drugs in the areas of neurology and psychiatry, dermatology and metabolism. R&D is concentrated in Frankfurt, with production in Reinheim/Darmstadt. Merz Pharmaceuticals spends almost a fifth of its sales on R&D and in 2006-2007 this amounted to €59.7 M. The products of the company include Axura®, Imex®, Belotero®, Hepa-Merz® etc.